CAR-T yo kurwanya Leukemia y’uturemangingo twa B (B-ALL)

B-ALL (Acute B-cell Lymphoblastic Leukemia) ni ubwoko bukomeye bwa kanseri y’amaraso, yibasira cyane cyane abana n’abakiri bato. Nubwo hari iterambere mu mikorere ya chimiotherapie gakondo, abarwayi benshi bagira ikibazo cyo gusubira inyuma cyangwa kudakira imiti. Ubuvuzi bwa CAR-T (Chimeric Antigen Receptor T-cell) ni uburyo bwiza bwo kuvura indwara z’ubudahangarwa bwagaragaje ko bufite icyo bugeraho mu kuvura B-ALL yasubiwemo cyangwa yasubiwemo, butanga icyizere ku barwayi bari bafite uburyo buke bwo kuvura.

Ubuvuzi bwa CAR-T ni uburyo bugezweho kandi bwihariye bukubiyemo guhindura uturemangingo twa T tw’umurwayi kugira ngo tumenye kandi twibasire uturemangingo twa kanseri. Kuri B-ALL, uturemangingo twa CAR-T twakozwe kugira ngo twibasire antigen ya CD19, poroteyine ikunze kuboneka ku buso bw’uturemangingo twa leukemia twa B. Iyo tumaze kongera kwinjira mu mubiri w’umurwayi, utwo turemangingo twa T twakozwe mu buryo bw’ikoranabuhanga dushaka no gusenya uturemangingo twa leukemia, bishobora gutuma tugabanuka igihe kirekire.

• Ikora neza cyane: Ubuvuzi bwa CAR-T bwagaragaje ko bufite intsinzi ikomeye mu kuvura B-ALL yongeye gusubira inyuma cyangwa idashobora kuvura, butanga igipimo cyo hejuru cyo koroherwa ku barwayi batakiriye uburyo gakondo bwo kuvura.
• Igikorwa cyagenewe: Mu kwibanda kuri antigen ya CD19, ubuvuzi bwa CAR-T bwibasira cyane cyane uturemangingo twa B-ALL, bigabanye kwangirika kw'uturemangingo tuzima.
• Uburyo bwo kuvura bwite: Kubera ko uturemangingo twa CAR-T dukomoka ku budahangarwa bw'umubiri bw'umurwayi, ubu buryo bwo kuvura bukorwa ku giti cye, byongera imikorere yabwo kandi bigabanya ibyago byo kwangwa.
• Imbabazi zirambye: Kenshi na kenshi, uburyo bwo kuvura bwa CAR-T bwatumye abarwayi bakira neza indwara, butuma babasha kubaho igihe kirekire ariko ntibasubire kurwara.

• Gukusanya uturemangingo twa TIntambwe ya mbere ikubiyemo gukusanya uturemangingo twa T mu maraso y'umurwayi binyuze mu buryo bwitwa leukapheresis.
• Utunyangingo twa T tw'ubwubatsi: Uturemangingo twa T twakusanyijwe duhindurwa muri laboratwari kugira ngo tugaragaze receptor ya chimeric antigen (CAR) yihariye kuri CD19, bikongera ubushobozi bwabyo bwo kwibasira uturemangingo twa B-ALL.
• Guteranya uturemangingo twa CAR-T: Nyuma y'igihe gito cy'ubwiyongere bw'uturemangingo, uturemangingo twa CAR-T twakozwe mu buryo bwa kinyabutabire twongera gushyirwa mu mubiri w'umurwayi binyuze mu guterwa mu mitsi (IV).
• Gukurikirana no Gusubiza mu buzima busanzwe: Nyuma yo guterwa umuti, abarwayi bakurikiranirwa hafi kugira ngo barebe ingaruka mbi zishobora kubaho nka cytokine release syndrome (CRS) ndetse n'uburozi bw'imitsi. Muri rusange, izi ngaruka zishobora gukemuka, kandi abarwayi benshi barakira iyo habayeho uburyo bukwiye bwo gufata imiti.

• Ikoranabuhanga rigezwehoBIOOCUS ikoresha ikoranabuhanga rigezweho kugira ngo ikore neza uturemangingo twa CAR-T kandi itange umusaruro mwiza ku barwayi.
• Itsinda ry'abaganga b'inzobere: Itsinda ryacu ry’inzobere mu by’amaraso n’ubuvuzi bw’ubudahangarwa ryihaye intego yo gutanga ubuvuzi bwihariye no kunoza intsinzi ya buri buvuzi.
• Ubunararibonye Mpuzamahanga: Dutanga ubuvuzi bwa CAR-T ku barwayi baturutse impande zose z'isi, hamwe n'amateka y'ubuvuzi bwiza kandi butuma abarwayi ba B-ALL bakira neza igihe kirekire.
• Ubuvuzi bwuzuye: Kuva ku nama ya mbere kugeza ku gukurikirana, BIOOCUS itanga ubuvuzi bwuzuye, igenzura ko abarwayi bahabwa ubuvuzi bwiza bushoboka muri buri cyiciro.

Igeragezwa riherutse gukorwa mu buvuzi n'amakuru agezweho yagaragaje ko ubuvuzi bwa CAR-T kuri B-ALL butanga ibisubizo bidasanzwe, cyane cyane ku barwayi basubiye mu burwayi cyangwa banze kuvura gakondo. Ubwo buvuzi bwakomeje kugaragaza ko hari umubare munini w'abasubije ububabare, aho abarwayi benshi bagera ku buremere bwuzuye kandi bagakomeza kubaho igihe kirekire.

Muri BIOOCUS, twavuje neza abarwayi benshi bafite B-ALL dukoresheje ubuvuzi bwa CAR-T, kandi ibyavuyemo byari byiza cyane. Kugira ngo usobanukirwe neza inkuru z'intsinzi n'ibyavuye mu buzima busanzwe, reba inyigo zikurikira ku barwayi:

• Inkuru y'umurwayi: B-ALL ifite ibyago byinshi, Guterwa igufwa ry'umusemburo w'amagufwa ku mezi 9—Imyaka ibiri nyuma yaho, Intangiriro nziza
• Kuva ku kunanirwa kwa mbere kwa grafting kugeza ku gukira burundu: Urugendo rw'umurwayi mu gutera Lu Daopei mu buryo bugezweho
• Amakuru ku bicuruzwa bya Leukemia ikabije ya Lymphoblastic (B-ALL) n'inyigo ku isuzuma ry'ibizamini

Izi ndwara zigaragaza ubushobozi bwo guhindura ubuvuzi bwa CAR-T ku barwayi ba B-ALL, zigaragaza ubushobozi bw'ubuvuzi ndetse n'ubushobozi bwo guha abarwayi amahirwe ya kabiri yo kubaho.

Ibimenyetso bya CD19+20CAR-T:Abarwayi bafite lymphoma ya B-cell non Hodgkin

Ibimenyetso bya CD19+22CAR-T:Kuvura abarwayi ba kanseri y'amaraso ya B-lymphocytic basubiye inyuma kandi badafite CD19

Ibimenyetso bya BCMACAR-T:Kuvura myeloma nyinshi yasubiwemo kandi idashobora kuvura